Effect of high-intensity statin preloading on TIMI flow in patients presenting with ST-elevation myocardial

Ahmed Shawky Elserafy1, Nabil Mahmoud Farag2, Ahmed Ibrahim El Desoky2

  • 1Cardiology Department, Faculty of Medicine, Ain Shams University, Abbassia square, Abbasia, Cairo, 11566, Egypt. ahmedshawkyelserafy@gmail.com.

Insights

High-intensity statin therapy before primary percutaneous coronary intervention (PCI) significantly improved myocardial perfusion and ST-segment resolution in ST-elevation myocardial infarction (STEMI) patients. This pre-PCI statin approach enhances outcomes in acute myocardial infarction.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Pharmacology

Background:

  • Acute ST-elevation myocardial infarction (STEMI) remains a leading global cause of death and disability.
  • Primary percutaneous coronary intervention (PCI) has improved STEMI outcomes, but further therapeutic advancements are needed for optimal myocardial reperfusion.
  • Investigating the role of pre-procedural medical therapy, specifically high-intensity statins, is crucial for enhancing myocardial perfusion.

Purpose of the Study:

  • To evaluate the impact of high-intensity statin administration prior to primary PCI on myocardial perfusion in acute STEMI patients.
  • To assess the effect of pre-procedural high-intensity statins on post-PCI thrombolysis in myocardial infarction (TIMI) flow grade, myocardial blush grade (MBG), and ST-segment resolution.

Main Methods:

  • A study involving 170 acute STEMI patients undergoing primary PCI at Ain Shams University Hospitals.
  • Patients were randomized into two groups: one receiving high-intensity statins (atorvastatin 80mg or rosuvastatin 20mg) before PCI, and a control group receiving standard care with statins initiated post-PCI.
  • Key outcome measures included post-interventional TIMI flow grade, MBG, and ST-segment resolution.

Main Results:

  • The high-intensity statin group demonstrated statistically significant improvements in post-procedural TIMI flow grade (P=0.010) and myocardial blush grade (P=0.010) compared to the control group.
  • Complete ST-segment resolution was significantly higher in the high-intensity statin group (40%) versus the control group (22.4%) (P=0.013).
  • Ejection fraction was also significantly improved in the high-intensity statin group (45.91 ± 5.49) compared to the control group (43.01 ± 8.80) (P=0.011).

Conclusions:

  • Pre-procedural high-intensity statin loading significantly enhances myocardial perfusion, as evidenced by improved TIMI flow and MBG post-primary PCI.
  • The administration of high-intensity statins before primary PCI is associated with a greater likelihood of complete ST-segment resolution.
  • High-intensity statin therapy prior to primary PCI positively impacts left ventricular ejection fraction in STEMI patients.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
147
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
518
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
750
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
130
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
166
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
169